InvestorsHub Logo
Followers 18
Posts 1876
Boards Moderated 0
Alias Born 10/21/2011

Re: None

Saturday, 08/08/2020 2:03:07 PM

Saturday, August 08, 2020 2:03:07 PM

Post# of 118383
The Company is focused on the IMMUNOLOGY and IMMUNOTHERAPY space. The Company is focused on rapidly advancing novel technologies through pre-clinical and Phase I/ II clinical trials. Currently, the Company is focused on small molecule therapies for treating cancer and autoimmune disorders. Additional information on Regen BioPharma is available at http://www.regenbiopharmainc.com.